Health

Vaccine Market Forecast, Revenue, Demand, Growth and Key Companies Valuation by 2028

September 7, 2021

The global vaccine market size is expected to reach USD 77.90 Billion at a steady revenue CAGR of 7.1% in 2028, according to latest analysis by Emergen Research. An increase in prevalence of infectious diseases is a key factor driving global vaccine market revenue growth. The report provides Vaccine market forecast, supported by detailed insights historical data and revenues, past and current market trends, industry trends, consumer trends, market size, market share, market growth, along with ranging impacts of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in market size over the forecast period, 2024–2028. Rise in prevalence of infectious diseases globally increases the healthcare burden of diseases on countries and affects their socio-economic development. The report includes profiles of major players in the market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials.

Download FREE Sample Brochure (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/290

Emergence of drug-resistant microbial strains that have affected the fight against infectious diseases such as pneumonia, cholera, malaria, and diarrhea, among others. Global Vaccine market forecast has been provided following thorough study, focus, comparison, and analysis of a varying range of factors and past market forecast and present outcomes. Vaccine Market forecast is made possible through, but has not been limited to, a study and analysis of a variety of factors and trends, and these are verified through interviews with industry experts and companies operating in the market. Rising demand for new drugs to replace those that have lost effectiveness and investment in research and development of vaccines is augmenting growth of the market. Rising focus by major companies on product/service expansion into new and untapped domestic markets, increasing investments in strategic agreements, favourable government policies and regulations, and growing competition in the market are some major trends observed in the Vaccine market. Development of more advanced offerings is driving rising demand and deployment in respective sectors/industries, and this is expected to drive Vaccine market revenue growth to a significant extent over the forecast period.

Browse Full Report Description with TOC@ https://www.emergenresearch.com/industry-report/vaccine-market

Incorporated with Info-graphics, charts, 70 tables and 85 figures, this 250-page research report “Vaccine Market Size, Type, Application, End-Use Industry, Regional Outlook, Competitive Strategies and Forecasts, 2024 – 2027” is based on a complete research of the entire Global market and covering all its sub-segments through comprehensively thorough classifications. Insightful analysis and assessment are created from superior primary and secondary information sources with data and information derived from industry specialists across the value chain.

Some Key Highlights From the Report

In August 2024, Pfizer and BioNTech announced a collaboration with Brazil’s Eurofarma to manufacture COVID-19 vaccine doses for Latin American countries. COMIRNATY will be manufactured by Eurofarma with Pfizer’s and BioNTech’s COVID-19 vaccine manufacturing and supply chain network. Eurofarma will get raw materials for the drug from the U.S. and manufacturing will begin in 2024. Vaccine production is expected to exceed 100 million finished doses yearly which will be exclusively distributed within Latin America.
Monovalent vaccine segment revenue is expected to register a significant growth rate during the forecast period. A monovalent vaccine is designed to immunize single microorganism and antigen (for example, measles vaccine). This type of vaccine is preferable for development of a strong immune response.
Toxoid vaccines are administered to adults as well as children to protect them against tetanus and diphtheria. This vaccine is administered to induce an immune response to protect against disease caused by toxins secreted by specific bacteria. This vaccine is part of a course of multiple doses and booster shots are given when travelling to high-risk countries.
Influenza segment accounted for a significant revenue in 2024. Influenza vaccines are seasonal flu shot that protects against the 3–4 types of influenza viruses such as viral respiratory illness that spreads quite easily. The flu can lead to serious health complications and even death. CDC recommends a yearly influenza vaccine for people six months and older. Pregnant women should also get the vaccine during each pregnancy.

Request customized copy of Vaccine report@ https://www.emergenresearch.com/request-for-customization/290

Region wise performance of the Vaccine industry

North America Vaccine market forecast is expected to remain significantly positive in terms of revenue share between 2024 and 2028. In addition, North America Vaccine market revenue share is expected to remain comparatively larger than that of other regional markets from 2024 to 2028.

Asia Pacific registered fastest revenue CAGR in 2024, and the Vaccine market forecast is that this trend is expected to continue going ahead. Market forecast states that revenue share contribution from China, India, and South Korea is expected to remain robust till 2028.

Europe Vaccine market forecast is positive currently, with revenue growth expected to remain steady between 2024 and 2028. Robust focus on research and development initiatives by major firms and changing trends and demographics in countries in the region are some factors expected to continue to support Vaccine market growth.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Avail Discount on Vaccine Market Report@ https://www.emergenresearch.com/request-discount/290

The research provides answers to the following key questions:

What will be the growth rate and the market size of the Vaccine industry for the forecast period 2024-2027?
What are the major driving forces expected to impact the development of the Vaccine market across different regions?
Who are the major driving forces expected to decide the fate of the Vaccine industry worldwide?
Who are the prominent market players making a mark in the Vaccine market with their winning strategies?
Which Vaccine industry trends are likely to shape the future of the industry during the forecast period 2024-2027?
What are the key barriers and threats believed to hinder the development of the industry?
What are the future opportunities in the Vaccine market?

Why Choose Emergen Research?